WO1991007164A1 - Desodorierende kosmetische mittel - Google Patents
Desodorierende kosmetische mittel Download PDFInfo
- Publication number
- WO1991007164A1 WO1991007164A1 PCT/DE1990/000837 DE9000837W WO9107164A1 WO 1991007164 A1 WO1991007164 A1 WO 1991007164A1 DE 9000837 W DE9000837 W DE 9000837W WO 9107164 A1 WO9107164 A1 WO 9107164A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lantibiotics
- cosmetic deodorants
- cosmetic
- nisin
- content
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/05—Stick
Definitions
- the present invention relates to cosmetic deodorants.
- Such formulations serve to eliminate body odor that arises when the odorless fresh sweat is decomposed by microorganisms.
- the commercial cosmetic deodorants are based on different active principles.
- Antimicrobial substances can reduce the bacterial flora on the skin. Ideally, only the odor-causing microorganisms should be destroyed. In practice, however, it has been found that the entire microflora of the skin are damaged to the same extent. Occasionally, even the microorganisms that do not produce an odor are more severely damaged.
- body odor can also be masked by fragrances, the classic method that least meets the aesthetic needs of the consumer, since the mixture of body odor and perfume smells rather unpleasant.
- Deodorants should meet the following conditions:
- liquid deodorants for example aerosol sprays, roll-ons and the like
- solid preparations for example deodorant sticks ("sticks"), powders and powder sprays
- sticks for example deodorant sticks
- the object of the present invention was to develop cosmetic deodorants which Not have disadvantages of the prior art.
- the deodorants should largely protect the microflora of the skin, but selectively reduce the microorganisms that are responsible for body odor.
- Lantibiotics have been known for many years. They are polypeptides that are synthesized by microorganisms and are characterized by the presence of lanthionine in the peptide sequence.
- the lanthionins have the following structures:
- ring structures are formed in the lantibiotics.
- lantibiotics are nisin, epiderin, subtilin, cinra ycin, duramycin, ancovenin, gallidermin, pep 5.
- nisin is a 34 amino acid peptide synthesized by Streptococcus lactis. It mainly works against micrococci and coryneform bacteria. In some countries it is an antibiotic approved as a food preservative (not in Germany).
- Nisin has the following amino acid sequence (primary structure):
- Epidermin is a lantibiotic isolated from microorganisms found on human skin.
- the use of epidermin as a topically active antibiotic / therapeutic agent is described in EP-A-0 181 578. It is used to fight infectious diseases. Only the therapeutic, not the cosmetic, use of epidermin is described.
- Gallidermin is a lantibiotic that differs from epidermin only by an amino acid.
- nisin and related lantibiotics can be interpreted as follows: Cell walls are destroyed by the release of autolysins. Since channels are also formed in the cytoplasmic amembrane, low-molecular cell components can diffuse out, as a result of which the (prokaryotic) cell is destroyed.
- Eukaryotic cells i.e. skin cells, fungi, etc., are resistant to nisin and other lantibiotics.
- Lantibiotics are practically non-toxic to warm-blooded animals.
- the LD50 for nisin is greater than 7 g / kg (determined for rats and cats).
- compositions according to the invention are not only suitable for cosmetic purposes, but moreover are more effective and gentler than the compositions of the prior art.
- the lantibiotics are preferably present in concentrations of 0.1-10000 ppm.
- the lantibiotics are particularly preferably present in concentrations of 0.1-750 ppm, very particularly preferably in concentrations of 0.5-400 ppm.
- the concentration information relates in each case to the content of pure active ingredient and to the total weight of the composition.
- Formulations with an effective content of nisin, epidermin and / or gallidermin have proven to be particularly advantageous.
- the other lantibiotics mentioned are also well suited for the use according to the invention.
- compositions according to the invention It is possible and possibly advantageous to use a mixture of lantibiotics as an effective principle of the compositions according to the invention.
- compositions according to the invention it is advantageous to adjust the compositions according to the invention to a pH range of 2.5-6.5 buffer. It is particularly favorable to choose the pH in a range from 3.5 to 4.8.
- additives into the compositions which increase the stability of the lantibiotics, for example preservatives, antioxidants, other proteins, photostabilizers, etc.
- the lantibiotics can be easily incorporated into the compositions according to the invention. They are preferably added in dissolved form (e.g. as an aqueous, alcoholic or alcoholic-aqueous solution) to the other constituents of the formulations. However, it is particularly advantageous to incorporate lantibiotics into so-called powder sprays. It is also advantageous to avoid additives that can damage the natural microflora, since the lantibiotics themselves selectively reduce the odor-producing microorganisms.
- the suspension bases for this can advantageously be selected from the group Aerosil magnesium carbonate, magnesium oxide, kieselguhr, kaolin, talc, modified starch, metal soaps (e.g. zinc stearate), titanium dioxide, aluminum oxide, calcium carbonate, zinc oxide, silk powder, nylon powder, Polyethylene powder and related substances.
- compositions according to the invention were tested against placebos, ie identical compositions except for the active substance content.
- a group of 40 subjects had to treat one armpit with the composition according to the invention and the other with placebo.
- the subjects then wore a shirt with panty liners under their armpits for three hours. After this time, the panty liners were transferred to separate bottles.
- the smell of the insoles was assessed by three test persons. The test was carried out as a double-blind test, so that neither the test subjects nor the test subjects knew which armpit had been treated with which composition.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019920701127A KR927003005A (ko) | 1989-11-16 | 1990-11-02 | 화장용 탈취제 |
US07/852,151 US5318778A (en) | 1989-11-16 | 1990-11-02 | Deodorizing lantibiotic cosmetic agents |
EP90916115A EP0500605B1 (de) | 1989-11-16 | 1990-11-02 | Desodorierende kosmetische mittel |
DE59009034T DE59009034D1 (de) | 1989-11-16 | 1990-11-02 | Desodorierende kosmetische mittel. |
AU66172/90A AU655915B2 (en) | 1989-11-16 | 1990-11-02 | Cosmetic deodorants |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP3938140.4 | 1989-11-16 | ||
DE3938140A DE3938140A1 (de) | 1989-11-16 | 1989-11-16 | Desodorierende kosmetische mittel |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1991007164A1 true WO1991007164A1 (de) | 1991-05-30 |
Family
ID=6393672
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1990/000837 WO1991007164A1 (de) | 1989-11-16 | 1990-11-02 | Desodorierende kosmetische mittel |
Country Status (11)
Country | Link |
---|---|
US (1) | US5318778A (de) |
EP (1) | EP0500605B1 (de) |
JP (1) | JP2997545B2 (de) |
KR (1) | KR927003005A (de) |
AT (1) | ATE121932T1 (de) |
AU (1) | AU655915B2 (de) |
CA (1) | CA2068410A1 (de) |
DE (2) | DE3938140A1 (de) |
ES (1) | ES2072452T3 (de) |
WO (1) | WO1991007164A1 (de) |
ZA (1) | ZA908858B (de) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994005156A1 (de) * | 1992-09-05 | 1994-03-17 | Beiersdorf Ag | Germicide wirkstoffkombinationen |
US5710124A (en) * | 1993-08-20 | 1998-01-20 | Novartis Corporation | Method for combatting bovine mastitis |
US6211240B1 (en) | 1993-05-18 | 2001-04-03 | Novartis Corporation | O-benzyl oxime ether derivatives and their use as pesticides |
FR2847165A1 (fr) * | 2002-11-15 | 2004-05-21 | Jean Noel Thorel | Utilisation de la nisine dans des formulations cosmetiques et/ou pharmaceutiques a usage topique |
FR2961508A1 (fr) * | 2010-06-17 | 2011-12-23 | Oreal | Derives d'acide amine ; compositions les contenant ; utilisation comme agent de traitement de la transpiration humaine |
FR2961509A1 (fr) * | 2010-06-17 | 2011-12-23 | Oreal | Derives d'acide amine ; compositions les contenant ; utilisation comme agent de traitement de la transpiration humaine |
EP1768646B1 (de) | 2004-06-17 | 2018-05-09 | Unilever PLC | Kosmetiksprays |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5512269A (en) * | 1993-06-09 | 1996-04-30 | Burroughs Wellcome, Co. | Method of treating retained pulmonary secretions |
DE19548013A1 (de) | 1995-12-21 | 1997-06-26 | Beiersdorf Ag | Verfahren zur Herstellung von O/W- oder O/W/O-Emulsionen sowie nach solchen Verfahren erhältliche O/W- und O/W/O-Emulsionen |
IL121709A0 (en) | 1997-09-04 | 1998-02-22 | Innoscent Ltd | Antibacterial deodorizing compositions |
DE19844262B4 (de) | 1998-09-26 | 2018-12-06 | Beiersdorf Ag | Kosmetische und dermatologische Zubereitungen in Form von O/W-Emulsionen mit einem Gehalt an niedermolekularen Siliconen |
ATE298233T1 (de) | 2000-02-19 | 2005-07-15 | Goldschmidt Gmbh | Kosmetische und pharmazeutische öl-in-wasser- emulsionen von polyethermodifizierten polysiloxanen |
US6485715B1 (en) | 2001-05-23 | 2002-11-26 | The Proctor & Gamble Company | Stable pressurized antiperspirant compositions containing dimethylether propellant and a low polarity solvent |
DE10139580A1 (de) * | 2001-08-10 | 2003-02-20 | Beiersdorf Ag | Kosmetische und dermatologische Zubereitungen in Form von O/W-Emulsionen mit einem Gehalt an Sterinen und/oder C12-C40-Fettsäuren |
DE10143964A1 (de) * | 2001-09-07 | 2003-03-27 | Basf Ag | Emulgatorarme oder emulgatorfreie Systeme vom Typ Öl-in-Wasser mit einem Gehalt an Stabilisatoren und einem aminosubstituierten Hydroxybenzophenon |
DE10143960A1 (de) * | 2001-09-07 | 2003-03-27 | Basf Ag | Kosmetische und dermatologische Zubereitungen in Stiftform, enthaltend ein aminosubstituiertes Hydroxybenzophenon |
DE10143962A1 (de) * | 2001-09-07 | 2003-03-27 | Basf Ag | Kosmetische und dermatologische Zubereitungen in Form von O/W-Emulsionen, enthaltend ein aminosubstituiertes Hydroxybenzophenon |
DE10143963A1 (de) * | 2001-09-07 | 2003-03-27 | Basf Ag | Kosmetische und dermatologische Zubereitungen in Form von W/O-Emulsionen, enthaltend ein aminosubstituiertes Hydroxybenzophenon |
EP2269656B1 (de) * | 2002-07-15 | 2014-08-20 | Board Of Regents, The University Of Texas | Ausgewählte antikörper mit bindung an aminophospholipide und ihre verwendung bei der behandlung von krebs |
US7378386B2 (en) | 2002-07-15 | 2008-05-27 | Board Of Regents, The University Of Texas System | Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives |
DE10330609A1 (de) | 2003-07-07 | 2005-01-27 | Beiersdorf Ag | Fixierende Mehrfachgestaltung der Frisur erlaubende kosmetische Zubereitung |
DE10332928A1 (de) | 2003-07-19 | 2005-02-03 | Beiersdorf Ag | Antitranspirantgel |
DE10333710A1 (de) | 2003-07-23 | 2005-02-24 | Beiersdorf Ag | Kosmetische, dermatologische oder pharmazeutische Zubereitungen auf Basis von Gase enthaltenden Lipid/Wachs-Gemischen |
BR0304620A (pt) * | 2003-10-17 | 2005-06-14 | Natura Cosmeticos Sa | Composição cosmética compreendendo um agente formador de filme |
DE102005017032B4 (de) * | 2004-04-27 | 2009-12-17 | Beiersdorf Ag | Kosmetische Formulierung enthaltend Mandelsäure |
EP1802376B1 (de) | 2004-04-27 | 2009-05-27 | Beiersdorf AG | Transparente kosmetische oder dermatologische formulierung |
GB0418766D0 (en) * | 2004-08-23 | 2004-09-22 | Koninkl Philips Electronics Nv | A computer programmed with gps signal processing programs |
WO2006069998A2 (de) | 2004-12-27 | 2006-07-06 | Beiersdorf Ag | Glycopyrrolat in kosmetischen zubereitungen |
DE102005003164A1 (de) | 2005-01-21 | 2006-07-27 | Goldschmidt Gmbh | Polyglycerinpartialester von Polyricinolsäure und mehrfunktionellen Carbonsäuren und deren Verwendung zur Herstellung von Emulsionen und Dispersionen |
US7638477B2 (en) * | 2005-03-09 | 2009-12-29 | Alberto-Culver Company | Sustained-release fragrance delivery system |
DE102005011785A1 (de) | 2005-03-11 | 2006-09-21 | Goldschmidt Gmbh | Langzeitstabile kosmetische Emulsionen |
DE102005055519A1 (de) * | 2005-11-18 | 2007-08-30 | Beiersdorf Ag | Optisch attraktive Antitranspirant Formulierung |
DE102005056890A1 (de) | 2005-11-28 | 2007-05-31 | Institut für Umweltmedizinische Forschung gGmbH | Kosmetisches Verfahren zur Beeinflussung der Melaninbildung in der Haut |
DE102006011314A1 (de) | 2006-03-11 | 2007-10-18 | Peter Dr. Engels | Kosmetische Zubereitungen mit einem Zusatz aus der Baobab-Pflanze |
US7874756B2 (en) | 2006-06-07 | 2011-01-25 | Beiersdorf Ag | Kit for the application of a fluid preparation |
EP1939279B1 (de) | 2006-12-01 | 2012-07-11 | Symrise AG | Hautmodell |
DE102007003582A1 (de) | 2007-01-24 | 2008-07-31 | Dr. August Wolff Gmbh & Co. Kg Arzneimittel | Verwendung einer kosmetischen Zusammensetzung zur kosmetischen Behandlung der Haut |
EP2000124A1 (de) | 2007-06-08 | 2008-12-10 | Evonik Goldschmidt GmbH | Kosmetische und pharmazeutische Öl-in-Wasser-Emulsionen mit einem Esterquat |
DE102007027850A1 (de) | 2007-06-13 | 2008-12-24 | Beiersdorf Ag | Transparente kosmetische Formulierungen |
DE102007032642B4 (de) | 2007-07-11 | 2011-12-01 | Beiersdorf Ag | Verwendung von kurzkettigen Glykolen als antitranspirantwirksame Mittel |
DE102007035741A1 (de) | 2007-07-24 | 2009-02-05 | Beiersdorf Ag | Stabilisierung kosmetischer oder dermatologischer Formulierung enthaltend Mandelsäure |
DE102007035742A1 (de) | 2007-07-24 | 2009-01-29 | Beiersdorf Ag | Stabilisierung kosmetischer oder dermatologischer Formulierung mit Mandelsäure |
DE102007035139A1 (de) | 2007-07-25 | 2009-01-29 | Symrise Gmbh & Co. Kg | 3-(4-Hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanon und dessen Verwendung als antimikrobieller Wirkstoff |
DE102007040001A1 (de) | 2007-08-23 | 2009-02-26 | Evonik Goldschmidt Gmbh | Neue zwitterionische Verbindungen enthaltende Formulierungen und deren Verwendung |
DE102007041028A1 (de) | 2007-08-29 | 2009-03-05 | Evonik Goldschmidt Gmbh | Verwendung estermodifizierter Organopolysiloxane zur Herstellung kosmetischer oder pharmazeutischer Kompositionen |
DE102007049612A1 (de) | 2007-10-17 | 2009-06-10 | Evonik Goldschmidt Gmbh | Bioaktive Zusammensetzung für kosmetische Anwendungen |
DE102007055483A1 (de) | 2007-11-21 | 2009-05-28 | Evonik Goldschmidt Gmbh | Kosmetische und dermatologische Formulierungen enthaltend Isononylbenzoat |
JP5523338B2 (ja) | 2007-12-19 | 2014-06-18 | エヴォニク ゴールドシュミット ゲーエムベーハー | エマルジョン中の架橋ヒアルロン酸 |
DE102008009929A1 (de) | 2008-02-18 | 2009-08-20 | Symrise Gmbh & Co. Kg | 3-(4-Hydroxy-3-methoxyphenyl)-1(4-hydroxphenyl)-1-propanon und deren Verwendung in kosmetischen und pharmazeutischen Zubereitungen |
DE102009009004A1 (de) | 2008-02-18 | 2009-09-17 | Seaquist Perfect Dispensing Gmbh | Abgabevorrichtung mit einem kosmetischen Fluid |
DE102008022392A1 (de) | 2008-05-06 | 2009-11-12 | Evonik Goldschmidt Gmbh | Kosmetika enthaltend Zistrosenkraut-Extrakte |
DE102008001786A1 (de) | 2008-05-15 | 2009-11-26 | Evonik Goldschmidt Gmbh | Verwendung organomodifizierter Siloxanblockcopolymere als Pflegewirkstoff zur Pflege von menschlichen oder tierischen Körperteilen |
DE102008001788A1 (de) | 2008-05-15 | 2009-11-26 | Evonik Goldschmidt Gmbh | Verwendung organomodifizierter Siloxanblockcopolymere zur Herstellung kosmetischer oder pharmazeutischer Zusammensetzungen |
EP2019316B1 (de) | 2008-05-28 | 2011-05-11 | Symrise AG | Menschliches ex-vivo-Hautmodell |
DE102008041020A1 (de) | 2008-08-06 | 2010-02-11 | Evonik Goldschmidt Gmbh | Verwendung von Polysiloxanen mit quaternären Ammoniumgruppen zum Schutz von tierischen oder menschlichen Haaren vor Hitzeschädigung |
DE102008042149A1 (de) | 2008-09-17 | 2010-03-18 | Evonik Goldschmidt Gmbh | Kosmetische und dermatologische Formulierungen enthaltend Phenoxyalkylester |
US7772181B2 (en) | 2008-10-15 | 2010-08-10 | Danisco Us Inc. | Personal care compositions comprising modified variant Bowman Birk Protease Inhibitors |
US7803902B2 (en) | 2008-10-15 | 2010-09-28 | Danisco Us Inc. | Modified variant bowman birk protease inhibitors |
DE102008052341A1 (de) | 2008-10-20 | 2010-04-22 | Evonik Goldschmidt Gmbh | Verwendung von Pflegeformulierungen enthaltend einen Extrakt aus Mangostan |
DE102008059905A1 (de) | 2008-12-02 | 2010-06-10 | Beiersdorf Ag | Gelförmige Zubereitungen auf der Basis von Alkyl-Lactosiden |
EP2376052B1 (de) | 2008-12-15 | 2017-10-11 | Beiersdorf AG | Anorganisches gel und zusammensetzung sowie herstellungsverfahren dafür |
DE102009004270A1 (de) | 2009-01-07 | 2010-07-08 | Beiersdorf Ag | Aromatische Diole als antitranspirantwirksame Mittel |
DE102009004269A1 (de) | 2009-01-07 | 2010-07-08 | Beiersdorf Ag | Diole als antitranspirantwirksames Mittel |
JP5763048B2 (ja) | 2009-04-09 | 2015-08-12 | シムライズ アーゲー | 皮膚刺激低下剤としてトランス−tert−ブチルシクロヘキサノールを含む組成物 |
DE102009002371A1 (de) | 2009-04-15 | 2010-10-21 | Evonik Goldschmidt Gmbh | Verfahren zur Herstellung von geruchlosen Polyetheralkoholen mittels DMC-Katalysatoren und deren Verwendung in kosmetischen und/oder dermatologischen Zubereitungen |
DE102010002558A1 (de) | 2009-11-20 | 2011-06-01 | Symrise Ag | Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe |
WO2011061144A2 (en) | 2009-11-20 | 2011-05-26 | Basf Se | The present invention relates to the use of beta-(1, 3)- beta-(1, 4) glucan with an average molecular weight of from 5.000 to 150.000 da for the increase of synthesis of collagen |
FR2954140A1 (fr) * | 2009-12-17 | 2011-06-24 | Oreal | Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques |
FR2954138B1 (fr) * | 2009-12-17 | 2012-03-02 | Oreal | Procede cosmetique de traitement des odeurs corporelles utilisant une composition a base de bacteriocines |
EP2389922A1 (de) | 2010-05-25 | 2011-11-30 | Symrise AG | Cyclohexylcarbamatverbindungen als Anti-ageing-Wirkstoffe |
EP2540170A1 (de) | 2011-06-29 | 2013-01-02 | Evonik Degussa GmbH | Dermatologisch wirksamer Hefeextrakt |
EP2758041B1 (de) | 2011-09-20 | 2021-01-13 | Basf Se | Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung |
WO2012143576A2 (en) | 2012-08-23 | 2012-10-26 | Symrise Ag | Compounds for preventing, reducing and/or alleviating itchy skin condition(s) |
EP2712609A1 (de) | 2012-09-26 | 2014-04-02 | Bayer MaterialScience AG | Polyurethanharnstoff-Mischung für die Haut-, sowie Haarkosmetik |
WO2016100634A2 (en) | 2014-12-19 | 2016-06-23 | The Procter & Gamble Company | Composition for enhancing hair fiber properties |
DE102015214140A1 (de) | 2015-07-27 | 2017-02-02 | Beiersdorf Ag | Schweiß verringernde kosmetische Zubereitung |
DE102015214145A1 (de) | 2015-07-27 | 2017-02-02 | Beiersdorf Ag | Schweiß verringernde kosmetische Zubereitung |
DE102015214137A1 (de) | 2015-07-27 | 2017-02-02 | Beiersdorf Ag | Schweiß verringernde kosmetische Zubereitung |
DE102015214144A1 (de) | 2015-07-27 | 2017-02-02 | Beiersdorf Ag | Schweiß verringernde kosmetische Zubereitung |
DE102015214143A1 (de) | 2015-07-27 | 2017-02-02 | Beiersdorf Ag | Schweiß verringernde kosmetische Zubereitung |
DE102015214146A1 (de) | 2015-07-27 | 2017-02-02 | Beiersdorf Ag | Schweiß verringernde kosmetische Zubereitung |
DE102015226630A1 (de) | 2015-12-23 | 2017-06-29 | Beiersdorf Ag | Verfahren zur Schweißreduktion |
WO2017132308A1 (en) | 2016-01-29 | 2017-08-03 | The Procter & Gamble Company | Composition for enhancing hair fiber properties |
DE102016217947A1 (de) | 2016-09-20 | 2018-03-22 | Beiersdorf Ag | Kit mit verbesserten porösen Schwammapplikatoren |
CN110573141A (zh) | 2017-04-28 | 2019-12-13 | 西姆莱斯有限公司 | 欧蓍草鲜榨植物汁浓缩物、制造和应用 |
JP7231617B2 (ja) | 2017-08-31 | 2023-03-01 | ビーエーエスエフ ソシエタス・ヨーロピア | 生理学的冷涼活性成分の使用、及びそのような活性成分を含む組成物 |
WO2018154145A2 (en) | 2018-03-29 | 2018-08-30 | Symrise Ag | Compounds for skin improvement / treatment |
DE102018207702A1 (de) | 2018-05-17 | 2019-11-21 | Beiersdorf Ag | Verfahren zur Schweißreduktion mit Malonsäure |
CN113908256B (zh) * | 2021-11-26 | 2023-05-26 | 中国农业科学院兰州兽医研究所 | Lancl1蛋白在制备抗病毒药物中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2359225A1 (de) * | 1973-11-28 | 1975-06-12 | Bayer Ag | Desodorantien |
EP0181578A2 (de) * | 1984-11-06 | 1986-05-21 | Dr. Karl Thomae GmbH | Antibiotisches Polypeptid, Verfahren zu seiner Herstellung und seine Verwendung |
EP0342486A1 (de) * | 1988-05-18 | 1989-11-23 | Dr. Karl Thomae GmbH | Antibiotikum |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2039074A1 (de) * | 1968-06-17 | 1971-03-18 | Sutures Inc | Gegenstand mit langanhaltenden keimtoetenden Eigenschaften und Verfahren zu dessen Herstellung |
JPS60149527A (ja) * | 1984-01-17 | 1985-08-07 | Seikenkai | 生体内脱臭剤 |
DE3523478A1 (de) * | 1985-07-01 | 1987-01-08 | Thomae Gmbh Dr K | Antibiotisches polypeptid, verfahren zu seiner herstellung, dieses polypeptid erzeugender stamm vom staphylococcus epidermidis, dieses polypeptid enthaltende zubereitungsformen und seine verwendung zur bekaempfung infektioeser erkrankungen |
DE3440423A1 (de) * | 1984-11-06 | 1986-05-07 | Dr. Karl Thomae Gmbh, 7950 Biberach | Antibiotisches polypeptid, verfahren zu seiner herstellung, dieses polypeptid erzeugender stamm von staphylococcus epidermidis, dieses polypeptid enthaltende zubereitungsformen und seine verwendung zur bekaempfung infektioeser erkrankungen |
US5135910A (en) * | 1988-06-22 | 1992-08-04 | The Public Health Research Institute Of The City Of New York | Nisin compositions for use as enhanced, broad range bactericides |
US4980163A (en) * | 1989-03-01 | 1990-12-25 | Public Health Research Institute Of The City Of New York | Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection |
US4996055A (en) * | 1989-06-05 | 1991-02-26 | Kurasawa Optical Industry Co., Ltd. | Deodorized bacteria composition |
-
1989
- 1989-11-16 DE DE3938140A patent/DE3938140A1/de active Granted
-
1990
- 1990-11-02 WO PCT/DE1990/000837 patent/WO1991007164A1/de active IP Right Grant
- 1990-11-02 AT AT90916115T patent/ATE121932T1/de not_active IP Right Cessation
- 1990-11-02 ES ES90916115T patent/ES2072452T3/es not_active Expired - Lifetime
- 1990-11-02 AU AU66172/90A patent/AU655915B2/en not_active Ceased
- 1990-11-02 JP JP2514697A patent/JP2997545B2/ja not_active Expired - Lifetime
- 1990-11-02 KR KR1019920701127A patent/KR927003005A/ko not_active Application Discontinuation
- 1990-11-02 EP EP90916115A patent/EP0500605B1/de not_active Expired - Lifetime
- 1990-11-02 DE DE59009034T patent/DE59009034D1/de not_active Expired - Fee Related
- 1990-11-02 US US07/852,151 patent/US5318778A/en not_active Expired - Fee Related
- 1990-11-02 CA CA002068410A patent/CA2068410A1/en not_active Abandoned
- 1990-11-05 ZA ZA908858A patent/ZA908858B/xx unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2359225A1 (de) * | 1973-11-28 | 1975-06-12 | Bayer Ag | Desodorantien |
EP0181578A2 (de) * | 1984-11-06 | 1986-05-21 | Dr. Karl Thomae GmbH | Antibiotisches Polypeptid, Verfahren zu seiner Herstellung und seine Verwendung |
EP0342486A1 (de) * | 1988-05-18 | 1989-11-23 | Dr. Karl Thomae GmbH | Antibiotikum |
Non-Patent Citations (1)
Title |
---|
Seifen - öle - Fette - Wachse, 97. Jg., Nr. 16, 5. August 1971, Ing. Chem. H. Bartl: "Kosmetik-Rohstoffe", Antibiotika als Deodorantien", Seite 556-557, siehe Abschnitte 5,6 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994005156A1 (de) * | 1992-09-05 | 1994-03-17 | Beiersdorf Ag | Germicide wirkstoffkombinationen |
US6211240B1 (en) | 1993-05-18 | 2001-04-03 | Novartis Corporation | O-benzyl oxime ether derivatives and their use as pesticides |
US6342633B1 (en) | 1993-05-18 | 2002-01-29 | Bayer Aktiengesellschaft | O-benzyl oxime ether derivatives and their use as pesticides |
US5710124A (en) * | 1993-08-20 | 1998-01-20 | Novartis Corporation | Method for combatting bovine mastitis |
FR2847165A1 (fr) * | 2002-11-15 | 2004-05-21 | Jean Noel Thorel | Utilisation de la nisine dans des formulations cosmetiques et/ou pharmaceutiques a usage topique |
EP1768646B1 (de) | 2004-06-17 | 2018-05-09 | Unilever PLC | Kosmetiksprays |
FR2961508A1 (fr) * | 2010-06-17 | 2011-12-23 | Oreal | Derives d'acide amine ; compositions les contenant ; utilisation comme agent de traitement de la transpiration humaine |
FR2961509A1 (fr) * | 2010-06-17 | 2011-12-23 | Oreal | Derives d'acide amine ; compositions les contenant ; utilisation comme agent de traitement de la transpiration humaine |
WO2011157612A3 (en) * | 2010-06-17 | 2012-06-28 | L'oreal | Amino acid derivatives; compositions containing them; use as agents for treating human perspiration |
WO2011157611A3 (en) * | 2010-06-17 | 2012-06-28 | L'oreal | Amino acid derivatives; compositions containing them; use as agents for treating human perspiration |
Also Published As
Publication number | Publication date |
---|---|
JPH05501875A (ja) | 1993-04-08 |
AU655915B2 (en) | 1995-01-19 |
DE3938140A1 (de) | 1991-08-08 |
DE3938140C2 (de) | 1992-01-23 |
AU6617290A (en) | 1991-06-13 |
EP0500605A1 (de) | 1992-09-02 |
KR927003005A (ko) | 1992-12-17 |
EP0500605B1 (de) | 1995-05-03 |
CA2068410A1 (en) | 1991-05-17 |
US5318778A (en) | 1994-06-07 |
DE59009034D1 (de) | 1995-06-08 |
JP2997545B2 (ja) | 2000-01-11 |
ZA908858B (en) | 1991-08-28 |
ES2072452T3 (es) | 1995-07-16 |
ATE121932T1 (de) | 1995-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0500605B1 (de) | Desodorierende kosmetische mittel | |
EP0658082B1 (de) | Germicide wirkstoffkombinationen | |
DE4429467C2 (de) | Desodorierende kosmetische Mittel | |
EP0658097B1 (de) | Desodorierende kosmetische mittel mit einem gehalt an fettsäuren | |
DE4324219C2 (de) | Desodorierende Wirkstoffkombinationen auf der Basis von alpha, omega-Alkandicarbonsäuren und Wollwachssäuren | |
DE69916197T2 (de) | Zusammensetzung die einen kühlenden Effekt hervorruft | |
DE10228837B4 (de) | Hautkosmetische Zusammensetzung und Verwendung der Zusammensetzung als Hautbräunungsmittel | |
DE3732154C2 (de) | Kosmetisches Sonnenschutz-Präparat für Gesicht und Körper | |
DE112007001469T5 (de) | Collagensynthese-Promotor, der Zink als aktiven Bestandteil enthält | |
DE19634019A1 (de) | Gegen Mikroogranismen, Viren, Parasiten und Protozoen wirksame Glycoglycerolipide | |
EP0596284A2 (de) | Antimycotische kosmetische und dermatologische Zubereitungen mit einem Gehalt an Fettsäureestern | |
JP2001131026A (ja) | 頭皮頭髪用化粧料 | |
DE4101122A1 (de) | Kosmetisches oder pharmazeutisches mittel | |
EP1068862A2 (de) | Desodorierende Wirkstoffkombination und deren Verwendung | |
DE602004009495T2 (de) | Desodorierende alkoholische Aerosolzusammensetzung enthaltend Zinksalicylat | |
DE4319546A1 (de) | Desodorierende kosmetische Zubereitungen mit einem Gehalt an Glycerinmonocaprylat und/oder Glycerinmonocaprinat | |
DE3318789A1 (de) | Deodorant | |
JPH05286843A (ja) | スエヒロタケ培養物含有皮膚化粧料 | |
WO2011026577A2 (de) | Zubereitungen mit wasserunlöslichen polymeren aminen zur verminderung von körpergeruch | |
DE19849218A1 (de) | Haut- und Haarbehandlungsmittel | |
EP3236917A1 (de) | Verwendung von octenidin als desodorierender wirkstoff | |
DE19643586A1 (de) | Gegen Mikroorganismen, Viren, Parasiten und Protozoen wirksame Sterole und Sterolderivate | |
EP3236916A1 (de) | Desodorierende zubereitung | |
DE4321753A1 (de) | Desodorierende Kosmetika mit einem Gehalt an alpha-omega-Alkandicarbonsäuren | |
DE10034137A1 (de) | Wirkstoffkombinationen aus 3-Iodo-2-propinyl-butylcarbamat und einem oder mehreren 4-Hydroxybenzoesäureestern und Zubereitungen, solche Wirkstoffkombinationen enthaltend |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1990916115 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2068410 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1990916115 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1990916115 Country of ref document: EP |